feed,title,long_url,short_url
Benzinga,"Analyst Beefs Up Beam Therapeutics Price Target, Says 'Reward Is Now Skewed To Upside'",https://benzinga.com/general/biotech/22/12/30149540/analyst-beefs-up-beam-therapeutics-price-target-says-reward-is-now-skewed-to-upside,https://da.gd/DoVa33
